Gentian Diagnostics AS (OSL:GENT) Total Assets : kr229.7 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS Total Assets?

Gentian Diagnostics AS's Total Assets for the quarter that ended in Dec. 2024 was kr229.7 Mil.

During the past 12 months, Gentian Diagnostics AS's average Total Assets Growth Rate was 55.20% per year. During the past 3 years, the average Total Assets Growth Rate was 14.40% per year. During the past 5 years, the average Total Assets Growth Rate was 16.80% per year. During the past 10 years, the average Total Assets Growth Rate was 16.20% per year.

During the past 12 years, Gentian Diagnostics AS's highest 3-Year average Total Assets Growth Rate was 57.60%. The lowest was 4.70%. And the median was 14.40%.

Total Assets is connected with ROA %. Gentian Diagnostics AS's annualized ROA % for the quarter that ended in Dec. 2024 was 63.02%. Total Assets is also linked to Revenue through Asset Turnover. Gentian Diagnostics AS's Asset Turnover for the quarter that ended in Dec. 2024 was 0.20.

Gentian Diagnostics AS Total Assets Historical Data

The historical data trend for Gentian Diagnostics AS's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gentian Diagnostics AS Total Assets Chart

Gentian Diagnostics AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

235.27

211.79

187.79

181.04

229.66

Gentian Diagnostics AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															181.04	186.59	186.86	189.10	229.66

Gentian Diagnostics AS Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Gentian Diagnostics AS's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	194.05	+	35.614
	=	229.7

Gentian Diagnostics AS's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	194.05	+	35.614
	=	229.7

Gentian Diagnostics AS (OSL:GENT) Total Assets Explanation

Total Assets is connected with ROA %.

Gentian Diagnostics AS's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	131.96	/	( (189.097	+	229.664)	/ 2 )
	=	131.96	/	209.3805
	=	63.02 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Gentian Diagnostics AS's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	42.61	/	( (189.097	+	229.664)	/ 2 )
=	42.61	/	209.3805
=	0.20

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Gentian Diagnostics AS Total Assets Related Terms

Thank you for viewing the detailed overview of Gentian Diagnostics AS's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Gentian Diagnostics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bjornasveien 5, Moss, NOR, 1596

Website

https://www.gentian.com

Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.